Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation

Hematology

Volumn 11, Issue 5-6, 2006, Pages 351-354

  Takatsuka, Hiroyuki ^a   Nakajima, Toshiyuki ^a   Nomura, Kaori ^a   Okikawa, Yoshiko ^a   Wakae, Takeshi ^a   Toda, Akinari ^a   Itoi, Hisayuki ^a   Okada, Masaya ^a   Misawa, Mahito ^a   Hara, Hiroshi ^a   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DEATH; ECHOCARDIOGRAPHY; FEMALE; GRAFT VERSUS HOST REACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HUMAN; LEUKOPENIA; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ATRIAL NATRIURETIC FACTOR; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34250720000     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600774991     Document Type: Article

References (16)

1. Childs, R., Chernoff, A. and Contentin, N. (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med, 343, pp. 750-758.
2. Slavin, S., Nagler, A. and Naparstek, E. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disease. Blood, 91, pp. 756-763.
3. Slavin, S. and Aker, M. (2001) Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: Past accomplishments and future goal. Cancer Chemother Pharmacol, 8, pp. S79-S84.
4. Fujimaki, K., Maruta, A. and Yoshida, M. (2001) Severe cardiac toxicity in hematological stem cell transplantation: Predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant, 27, pp. 307-310.
5. McDonagh, TA, Robb, SD and Murdoch, DP (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351, pp. 9-13.
6. Muders, F., Kromer, EP and Griese, DP (1997) Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J, 134, pp. 442-450.
7. Levin, E., Gardner, DG and Samson, PD (1998) Natriuretic peptides. N Eng J Med, 339, pp. 321-327.
8. Mukoyama, M., Nakao, K. and Saito, Y. (1991) Brain natriuretic peptide as a novel cardiac hormone: Evidence for an exqusive dual natriuretic peptide system, atrial natriuretic pedptide and brain natriuretic peptide. J Clin Invest, 87, pp. 1402-1412.
9. Yoshimura, M., Yasue, H. and Okumura, K. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 87, pp. 464-469.
10. Gottlieb, SS, Kukin, MC and Ahern, D. (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol, 13, pp. 1534-1539.
11. Omland, T., Aakvaag, A. and Bonarjee, VVS (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation, 93, pp. 1963-1969.
12. Arai, H., Nakao, K. and Narito, M. (1988) Augmented expression of atrial natriuretic polypeptid gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res, 62, pp. 926-930.
13. Saito, Y., Nakao, K. and Arai, H. (1995) Augmented secretion of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest, 44, pp. S61-S64.
14. Kohno, M., Horio, T. and Yokokawa, K. (1992) Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med, 92, pp. 29-34.
15. Nishikimi, T., Yoshihara, F. and Morimoto, A. (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension, 28, pp. 22-30.
16. Tsutamoto, T., Wada, A. and Maeda, K. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 96, pp. 509-516.